Delivery Order SPE2DB22D2211-SPE2DB26FRHEW
Award Date 10/28/25
Potential Completion Date 10/29/25
Potential Value $46K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,431.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This non-competitive delivery order was issued under an existing contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist indicated for weight management, reflecting the...
- The Defense Logistics Agency awarded a $8,787.92 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pens on May 12, 2025, with completion expected by May 13, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $47,062.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pen injections on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance...
- The Defense Logistics Agency awarded a $4,809.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This is an unset-aside, competitively awarded contract utilizing the company's existing Indefinite Delivery Contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $9,964.01 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 ml pens on August 13, 2025, with completion expected by August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist indicated for weight management and is part of the broader...
- The Defense Logistics Agency awarded a delivery order valued at $13,306.04 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a semaglutide injection used for weight management in adults with obesity or...
- The Defense Logistics Agency awarded a $3,741.88 delivery order to AmerisourceBergen Drug Corp for ZEPBOUND (semaglutide) 2.5 mg/0.5 mL pen auto-injectors on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ZEPBOUND is a GLP-1 receptor agonist medication approved for weight...
- The Defense Logistics Agency awarded a $13,859.30 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight management, representing part of the...
- The Defense Logistics Agency awarded a $25,072.55 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on a firm fixed price basis. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication primarily used for weight...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,262.71 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based pharmaceutical product used for weight...